Bloomage Biotechnology's controlling shareholder completes share increase plan

Beijing Tongsheng Law Firm issued a legal opinion confirming that Huaxi Xinyu, as the controlling shareholder of Bloomage Biotechnology, had the legal qualifications to implement the share increase plan. The plan was disclosed on August 8, 2025, with Huaxi Xinyu intending to increase its shareholding by at least 200 million yuan and not exceeding 300 million yuan.

The company announced on October 1, 2025, that Huaxi Xinyu completed its share increase plan, acquiring an additional 4,518,703 shares through centralized bidding on the Shanghai Stock Exchange from August 27, 2025, to September 30, 2025. This brings its total shareholding to 288,018,703 shares, representing 59.79% of the company's total share capital.

The total amount spent on the share increase was 257,478,738.40 yuan. Prior to the increase, Huaxi Xinyu held 58.86% of Bloomage Biotechnology's shares. This transaction does not trigger a tender offer and will not affect the company's listing status, governance structure, or ongoing operations.